Free Stock Tips
Tips, tactics and strategies
Hi Everybody,
We’ve been having a great week so far. Today’s alert may be the best one yet!
This company is starting to hit some major radars. It’s seeing a lot of interest because of its potential in the fast growing digital advertising and mobile applications market.
The company also has over $6 million in the bank so it’s poised for expansion.
Our alert for Thursday is:
SPYR, Inc.
Ticker symbol: SPYR
Last price: $0.65
SPYR is a holding company, that through its wholly-owned subsidiary, Franklin Networks, is engaged in digital publishing and advertising operations.
SPYR currently owns and operates nine websites focused on topics including, food, travel, fitness, nutrition, fashion and parenting.
By creating valuable and sharable content on these sites, SPYR will be able to leverage the traffic and synergies between the sites to offer advertisers package deals on secondary markets.
In case you haven’t noticed this whole “internet advertising” thing is kind of a big deal.
Online ad sales continue to register double-digit percentage growth year over year. In 2013, online ad sales rose 17 percent to $42.8 billion up from $26 billion in 2010 and only $9.6 billion in 2004. In the U.S., the total digital advertising spend alone will rise to more than $52 billion in 2015 and will climb to more than $61 billion by 2017. It is numbers like this that explain why the transition by SPYR into the digital publishing space makes a whole lot of sense.
Oh, and they’ve also entered into the mobile app space with the creation of SPYR APPS LLC.?
The timing is perfect to enter the multi-billion dollar apps and games industry. A recent article highlighting the apps industry found that by 2017, it’s expected that over 268 billion app downloads will generate $77 billion worth of revenue. The article points out that in 2015 alone, 1 billion smartphones will be purchased. The popularity of the smartphone isn’t slowing down, and with it the popularity of downloading apps is growing exponentially.
With numbers like that it’s clear to see why even the digital games industry has gone mobile. The mobile apps industry is expected to grow 16.5 percent in 2015 with gaming apps accounting for over 30 percent of the U.S. mobile content market in 2015.
Not to mention that the company is cash positive, with over $6 million in the bank! Meaning they already have capital in place which is more than most OTC companies can say.
With all this going on it’s not hard to see why investors are flocking to SPYR.
Make sure you’re ready to book your profits with SPYR!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: advertising, buy, Franklin Networks, publishing, SPYR
Hi Everybody,
Hope you had a good day yesterday, our drone call ran up 33% at one point.
Congratulations to everyone who booked profits!
So let’s keep it moving, to a penny with some big names involved, and looking like a major breakout is brewing.
Our alert for Wednesday is:
FONU2, Inc.
Ticker symbol: FONU
Last price: $0.09
FONU is a film studio, production and social commerce company actively developing a 1,560 acre film studio complex, “Studioplex” in Effingham County, Georgia.
Why Georgia?
• Georgia is #1 in growth nationwide for film in production ahead of both California and New York.
• Demand in Georgia far outweighs supply.
• Georgia currently has an inventory shortage estimated at over 20 soundstages to accommodate the entertainment business needs.
• Record government support including grants, rebates and tax incentives enhances profitability.
• In 2014 alone, Georgia feature films and television productions generated an economic impact of $5.1 billion.
• Qualifying productions receive up to a 30% tax credit.
Hollywood Elite Onboard
In addition to building the Studioplex, the company has also acquired the worldwide distribution rights to Nick Cassavete’s Yellow. Cassavete’s wrote and directed Yellow. He has also directed and wrote for many other notable films such as The Other Woman, The Notebook, John Q, and Blow to name a few.
FONU is also producing a film being directed by the legendary Penny Marshall, who directed According to Jim, A League of Their Own, Big,Jumpin’ Jack Flash, and Laverne & Shirley.
The Hollywood experience doesn’t end there as FONU recently appointed new COO Alice P. Neuhauser whose resume includes financing some of the largest independently financed pictures including Terminator 2, Cliffhanger, Basic Instinct and Total Recall.
Investment Highlights
• Largest studio project in America.
• Cost savings versus competing studios.
• Management team track record includes both the successful creation and construction of a leading production studio as well as producing over 200 movies, which have generated in excess of $3 billion in box office receipts.
FONU looks like it could have a huge week heading into their presentation at the Growth Capital Expo next week. With that in mind traders are snatching up shares, and this could be a major winner for anyone involved.
Make sure you’re ready to book your profits with FONU!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, film studio, FONU, FONU2, Nick Cassavete, Penny Marshall, Studioplex
Buy Golden Star Enterprises
In: Tips
7 Apr 2015Hi Everybody,
Commercial drones are hot!
Drones are poised to have a huge impact on the US economy, according to the world’s largest unmanned systems industry organization. The report released by the Association for Unmanned Vehicle Systems International (AUVSI) forecasts the total domestic impact to reach more than $82 billion.
Recently, a commercial drone stock VMRI, ran almost 200% from 2 bucks to almost 6 dollars!
So when we saw this news after market we knew we had to scramble and get a report to you ASAP!
The company we’re alerting you to, just released news after the bell that they acquired 100% of the licensing rights for manufacturing and distribution of North American Drones Enterprise Inc.’s (NAD) branded line of drone product!
Our alert for Tuesday is:
Golden Star Enterprises, Ltd.
Ticker symbol: GSPT
Last price: $0.09
NAD is in the business of producing and marketing drones to a wide range of potential users for commercial and recreational use. Drones, most commonly associated with military applications are increasingly developing civil applications.
Drone services include aerial surveying, aerial video and photography, search and rescue operations, inspecting power lines and pipelines, counting wildlife, delivery of supplies (particularly to remote areas), forest fire detection, surveillance, and much more. A large number of tasks performed from the ground today that are either personnel intensive, infrastructure intensive, or time intensive, can be more easily accomplished through the use of drones.
GSPT’s focus is to sell drones that make it easy for the everyday consumer to use and allow businesses to provide services new to their industry. The core business can be divided into two main areas:
1. The highly customized sales of drones in the “Mini”, the “Prosumer” and “commercial use” market segments; and,
2. The leasing of purpose built drones to assist the private sector in specific lines of work.
GSPT currently has three different drones in their brand and they are, The X Factor (18.5×18.5x2cm), Kasper (35x35x10cm) and I-Sky (80x40x42cm). What differentiates NAD from its competitors is that its drones are sold at a lower price point, and its drones can be operated by novices and experts alike.
GSPT through NAD has an exclusive co-branding, distribution agreement in place with one of the top drone makers in the world (manufacturer of “Ghost” drones) to sell co-branded drones throughout North America.
As we said, the drone market is going to be huge and investors are taking a bite at every opportunity they have to get into this market. GSPT may be the best option yet, and at this price point could bring investors back value very quickly.
Make sure you’re ready to book your profits with GSPT!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy PharmaCyte Biotech
In: Tips
25 Mar 2015Hi Everybody,
Everyday there’s a new biotech running, creating profit opportunities for savvy traders.
With this in mind we found a nice looking biotech, that has received FDA orphan drug designation for their pancreatic cancer treatment. They are in phase 2b of clinical trials which are expected to commence this year.
That’s not all, this pancreatic treatment is based on the company’s cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R) which may also be useful in treatment for other forms of cancer as well as diabetes.
The fact is this company has a real shot at making some waves as larger investors are more willing to take chances on little known biotechs due to the current market condition.
Our alert for Wednesday is:
PharmaCyte Biotech, Inc.
Ticker symbol: PMCB
Last price: $0.10
PMCB is a clinical stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box(R).
PMCB’s patented Cell-in-a-Box treatment, has earned FDA ‘orphan drug designation’, for the treatment of pancreatic cancer. They will be executing Phase 2b of their clinical trials vs. a treatment using Eli Lilly’s Gemzar and Celgene’s Abraxane®.
Celgene is a billion dollar market cap company, and Eli Lilly is even bigger…if PMCB’s trials are successful this could end up as a wild ride for early investors.
But even before any of that happens, the sheer potential of this story as it makes its rounds could make for some major price swings.
The smallcap biotech sector is leading the market, and PMCB is a beautiful opportunity at capitalizing on this trend.
Make sure you’re ready to book your profits with PMCB!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy Atlantic Wind & Solar
In: Tips
18 Mar 2015Hi Everybody,
The future looks bright for our alert for Wednesday. If you take a look at their recent numbers you will see why investors will be trampling over each other to buy shares in this up and coming solar company.
This company’s numbers tell the story:
• 19 consecutive quarters of improvement.
• 3 profitable quarters in a row.
• $5.4 million in sales for the first 9 months of 2014 (up almost 100% from 2013).
• $971,594 in profits for the first 9 months of 2014.
Our alert for Wednesday is:
Atlantic Wind & Solar, Inc.
Ticker symbol: AWSL
Last price: $0.34
AWSL is renewable energy asset developer, with emphasis on photovoltaic solar (PV) and wind energy.
AWSL’s portfolio is diversified across 22 municipalities in Canada and 5 regions in Central and South America including, Ecuador and Peru.
The growth of the global renewable energy industry has soared over the past decade yet it is still in its infancy.
AWSL is based in Canada which means big opportunities. Canada is a world leader in the production and use of energy from renewable resources. As a matter of fact, wind and solar photovoltaic energy are the fastest growing sources of electricity currently providing about 16.9% of the country’s total primary energy supply.
Recent News:
• Atlantic Wind & Solar Supplies More Power to the Ontario Power Authority.
• AWSL announced the addition of another utility scale solar plant in Ontario, Canada now powering the grid. The formal receipt of a notice of Commercial Operation (COD) from the Ontario Power Authority (OPA) marks the final step in the construction and connection of this solar plant.
• The solar power plant was developed by its Canadian subsidiary Atlantic Solar Inc.
• The photovoltaic plant consists of a 111.585 KW AC / 132.345 KW DC fixed array of 255W poly-crystalline modules. The power will be sold to the Ontario Power Authority for 20 years at a rate of $0.713/kWh.
Conclusion:
• AWSL is clearly a well run company and has the numbers to prove it.
• AWSL continues to sign agreements that will provide long term cash flow to the company and their portfolio continues to grow.
• There should be new numbers out soon, and because AWSL has improved 19 quarters in a row, it is pretty safe to say, they should be strong.
• With more and more investors learning about AWSL over the next few days this sleepy little stock is sure to get moving creating HUGE profit opportunities for those that get on board.
Make sure you’re ready to book your profits with AWSL!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy NHale – Again!
In: Tips
5 Mar 2015Hi Everybody,
We hope you managed to get on to yesterdays alert. VTEQD opened at .033 then traded to a high of .075 for a 127% price gain.
Let’s move on to another opportunity we’ve been following, it looks positioned for its next move.
Remember NHLE our pick from last week? That stock traded up 50% in just 2 days.
Well, NHLE has come back down to its major support area and should bounce, setting up a sweet trade.
If you missed last weeks trade, here is another opportunity to catch these easy gains!
If you missed last week’s alert, take a look at it here: http://www.stips.com/share-stock-tips/buy-nhale-2/
Highlights
• This company is a medical marijuana company.
• They are actively seeking acquisitions.
Our alert for Thursday is:
NHale, Inc.
Ticker symbol: NHLE
Last price: $0.112
NHLE acquires companies within the medical and recreational cannabis market.
NHLE announced last week that they project revenues exceeding $30 million in 2015. Those numbers should really excite any trader learning about this opportunity.
Make sure you’re ready to book your profits with NHLE!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy VeriTeQ
In: Tips
4 Mar 2015Hi Everybody,
Our alert for Wednesday looks amazing. We think we found a real gem here, the stock appears to be extremely undervalued based on recent news and traders taking positions at these levels will see tremendous upside.
Highlights:
• This company is a medical device company with FDA approved products.
• The US government passed legislation that should drive sales.
• This company is a potential takeover candidate.
Our alert for Wednesday is:
VeriTeQ Corporation
Ticker symbol: VTEQD
Last price: $0.03
VTEQD develops innovative, proprietary RFID technologies for implantable medical device identification, and dosimeter technologies for use in radiation therapy treatment.
VTEQD has proprietary technology, including over 100 patents, patents pending, patent licenses, and U.S. Food and Drug Administration cleared and CE marked products.
VTEQD has two principal business lines:
1. Unique Device Identification (UDI) for medical devices
2. Radiation dosimeters and other medical sensor applications.
What’s most interesting is their UDI technology. Branded as Q Inside Safety Technology, these little RFID chips VTEQD produces are placed in medical products such as breast implants.
One major issue this helps resolve is when there is a recall. Without the RFID tech, when there is a recall on a certain line of implants there’s no real way of knowing if someone’s implant should be recalled. With VTEQD’s UDI technology this will no longer be an issue.
Not only does it solve this problem, this kind of UDI technology is now being mandated by the FDA for reusable devices such as implant ‘sizers’.
In September 2013 FDA issued a Final Rule (“Rule”) which will require most medical devices sold in the U.S. to carry a UDI.
Now here’s where it gets interesting…
VeriTeQ Corporation executes term sheet for exclusive license of its Q Inside Safety Technology for the breast implant market with a $1.75 million up front payment.
VTEQD’s market cap is 42K. Can you say ‘undervalued’?
Not to mention, 80% of the breast implant market is controlled by Mentor and Allergen. Given the FDA requirements, and the cost of developing a technology like VTEQD’s, it would stand to reason that these two giants may take a long look at VTEQD as a possible acquisition.
All of these factors along with the fact the stock is only 3 cents a share make VTEQD a very intriguing opportunity. As more investors learn about this story the rush could create some huge price appreciation relatively quickly.
Make sure you’re ready to book your profits with VTEQD.
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, FDA, medical, Q Inside, radiation therapy, RFID, UDI, VeriTeQ, VTEQD
Hi Everybody,
Monday’s alert gained 33%, and our alert for Tuesday has the potential for big gains too, so let’s get right to it.
Highlights:
• This company is a medical marijuana company.
• They are actively seeking acquisitions.
Our alert for Tuesday is:
NHale, Inc.
Ticker symbol: NHLE
Last price: 11.8 cents
NHLE acquires companies within the medical and recreational cannabis market.
NHLE projects revenues exceeding $30 million in 2015! Those numbers should really excite any new trader learning about this opportunity.
NHLE CEO Lance Williams has 12 years experience in indoor agriculture and is referred to as a “Master Grower”, so this isn’t just some company trying to ride the cannabis wave. NHLE brings expertise to the market which should help them rise above the pack.
Toronto based investment group, Four Twenty Investments, certainly believes NHLE has explosive potential. They just committed 10 million dollars to NHLE to make more acquisitions.
NHLE is in the process of evaluating possible acquisitions.
You know what that means? Even more potential press releases that could send this stock flying.
With this big news, NHLE is sitting pretty and traders are on the edge of their seats, which means we may have a serious jump in liquidity and volatility this week.
Make sure you’re ready to book your profits with NHLE!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, cannabis, Four Twenty Investments, marijuana, medical, NHale, NHLE
Buy Definitive Rest Mattress Company
In: Tips
23 Feb 2015Hi Everybody,
If you liked Friday’s 15% gainer, you will love Monday’s alert.
Highlights:
• This stock trades under 1 cents.
• This stock has shown the ability to make gains for traders
Our alert for Monday is:
Definitive Rest Mattress Company, Inc.
Ticker symbol: DRMC
Last price: 0.0052
DRMC recently announced their plans to enter the billion dollar metal works industry for commercial aircraft and aerospace industries.
DRMC sees a great opportunity for revenue in these sectors, and plans to capitalize immediately through the acquisition of companies with strong growth and profit potential.
Their first acquisition:
NU Metals Technology
• Aerospace, commercial, industrial manufacturing, distribution and sales
• Company formed by industry veterans
• Combined 50 years of experience in the metals sales and CNC manufacturing industry
The aviation industry needs to replace older, less efficient airplanes to reduce the cost of air travel.
Industry experts forecast a long-term demand for 35,280 new airplanes, valued at $4.8 trillion.
That’s a pretty big demand pie DRMC’s new subsidiary is looking to take a bite of.
But look, we’re not telling you this is likely or not, what we are telling you is this particular setup seems to be making traders money, and you have an opportunity to benefit immediately on Monday.
Make sure you’re ready to book your profits with DRMC!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
Buy Cre8tive Works
In: Tips
20 Feb 2015Hi Everybody,
Many of you have sent emails asking for a quick trade idea to put some cash in your pockets, so here you go.
Highlights
• This stock trades under 2 cents.
• This stock has a history of making 50%, 100%, even a 400% move in a single day.
• There are lots of newsletters talking this one up tonight which means tomorrow should be a big day.
Our alert for Friday is:
Cre8tive Works, Inc.
Ticker symbol: FILM
Last price: $0.0165
FILM is in the business of financing media productions, specifically the financing of production ready, independent films and media projects that have potential for financial success.
FILM is already racking up the credits, which has investors excited.
• “Dead Air” (Executive Producer)
• “Behind Glass Walls” (Executive Producer)
• “Deposito Barbae” (Associate Producer)
• “The Fool” (Executive Producer);
• “Amara” (Producer);
• “Average & Uninteresting” (Associate Producer);
• “The Wild Adventures of BeBop Fuzz” (Associate Producer);
• “Sandal Brigade” (Series Producer)
Some of Hollywood’s biggest films of all time were independent movies. We’re sure hits like: The Blair Witch Project, Reservoir Dogs, Clerks, The Terminator, The Passion of the Christ, and Slumdog Millionaire all ring a bell.
History has proven to us that many low-budget independent films can turn into box office smash hits and that’s what makes FILM so attractive.
So let’s recap:
• FILM made big headway in 2014 and is set up for an even bigger 2015.
• FILM trades under 2 cents a share so every uptick means real money in your pocket.
• FILM is coming off its recent lows with much upside potential ahead.
• FILM is receiving a ton of exposure and that should create some great trade opportunities this Friday.
Make sure you’re ready to book your profits with FILM!
As always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.
Good Trading
- No Comments
- Tags: buy, Cre8tive Works, film, Media, movies